Remdesivir is actually contraindicated in patients with multiorgan dysfunction, vasopressor support, co-administration of other antivirals, elevated ALT or severe renal impairment19, as liver and kidney adverse drug effects have been stated in remdesivir-treated COVID-19 patients50. Here, GPT is linked to COVID-19.